Cortactin modulates RhoA activation and expression of Cip/Kip cyclin-dependent kinase inhibitors to promote cell cycle progression in 11q13-amplified head and neck squamous cell carcinoma cells.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples